<DOC>
	<DOCNO>NCT01229735</DOCNO>
	<brief_summary>To assess long-term effect levetiracetam retention rate subject refractory partial onset seizure fully control 1 3 concomitant antiepileptic drug , compare topiramate add-on therapy 52 week .</brief_summary>
	<brief_title>Levetiracetam Versus Topiramate Adjunctive Therapy Evaluate Efficacy Safety Subjects With Refractory Partial Onset Seizures</brief_title>
	<detailed_description />
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Etiracetam</mesh_term>
	<mesh_term>Topiramate</mesh_term>
	<mesh_term>Piracetam</mesh_term>
	<criteria>Male female subject 16 80 year , inclusive . Subjects 20 year may include legally permit ethically accepted Subjects refractory epilepsy partial onset seizure classifiable accord International League Against Epilepsy ( ILAE ) . Subjects least 2 partial onset seizures whether secondarily generalize 8 week historical baseline precede V1 accord ILAE classification Subjects least 1 partial onset seizures whether secondarily generalize per 4 week precede V2 accord ILAE classification Subjects interval partial onset seizure less 6 week entire 12 week ( 8 week precede V1 4 week precede V2 ) Subjects uncontrolled treat 1 3 permit concomitant AEDs . Permitted concomitant AEDs stable optimal dosage subject least 4 week V1 4 week precede V2 expect keep stable Treatment Period . Subjects present generalized epilepsy classify type II accord ILAE classification ( ref publication 1981 ) Subjects suffer epilepsy syndrome undetermined whether focal generalize ( classification III accord ILAE classification ) Subjects suffer special syndrome ( classification IV accord ILAE classification ) History occur cluster ( frequently indistinctly separate reliably count ) V2 . Presence exclusively type IA nonmotor seizure . History presence status epilepticus within last 3 month precede V1 Baseline History presence know pseudoseizures Subjects currently vigabatrin . ( Subjects receive vigabatrin past normal visual field test allow . ) Subject take 1 follow medication regular basis within 28 day prior Visit 1 : antipsychotic drug , psychostimulant ( amphetamine derivative )</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>levetiracetam</keyword>
	<keyword>topiramate</keyword>
	<keyword>epilepsy</keyword>
	<keyword>partial seizure</keyword>
</DOC>